Dental Infection Treatment Market – A market with high CAGR and return on investment by 2023

 

Global Dental Infection Treatment Market   - Overview

Dental infection or tooth abscess is an infection of teeth, gums and associated tissue caused by a bacterial infection. Tooth abscess leads to pus formation and if left untreated can lead to serious, even life-threatening, complications. The symptoms of a tooth abscess include severe, persistent, throbbing pain in the tooth which can radiate to the jawbone, neck and other associated parts of the head, fever, swelling in cheeks, swollen lymph nodes, sensitivity to hot and cold foods etc. The spread of infection results in foul smell and foul-taste in mouth. The periapical tooth abscess is the most dangerous as bacteria invade the dental pulp which is the innermost part of the tooth that contains blood vessels, nerves and connective tissue.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4068 

The market for dental infection treatment is highly fragmented due to large number of players especially in the drugs segment which has put pressure on the profit margin, rise of low quality and low cost drug products manufactured by companies operating from regions with poor regulatory framework which reduces the market of quality drug products. Also the market for dental infection treatment is highly dependent on product development strategy such as high quality fills and cements. The drug segment is growing at a slow pace due to saturation of the market. Considering all these factors, the market for dental infection treatment is expected to grow at a CAGR of ~ 8.6 % during 2017-2023.

According to the Centres for Disease Control and Prevention, in 2014, 19% of the children aged 5-19 years and 31% of adults aged 20-44 have untreated dental caries. According to the WHO, worldwide, 60–90% of school children and nearly 98% of adults have dental cavities, which often leading to pain and discomfort. According to findings from the Centres for Disease Control and Prevention, (2012), one out of every two American adults aged 30 and over has periodontal disease. According to findings from the Centres for Disease Control and Prevention in 2012, approximately 91 % of US adults aged 20–64 had dental caries in permanent teeth.

 Global Dental Infection Treatment Market   - Competitive Analysis

Kerr Corporation, Patterson Dental Supply, Inc., Henry Schein, Inc., Pfizer .Inc, Endo Pharmaceuticals, Johnson & Johnson, Taj Pharmaceuticals Limited, Septodont Healthcare India Pvt. Ltd., Bayer HealthCare, Ultradent Products Inc., Bristol-Myers Squibb, Daiichi Sankyo are some of the prominent players at the forefront of competition in the Global Dental Infection Treatment Market and are profiled in MRFR Analysis.   

Aug-16   - Henry Schein had announced that it had acquired 80% ownership of Marrodent, which is a full service dental distributer of Poland, thus marking Henry Schein’s entry into the dental market of Poland.

Jul-16 -  Kitron signed supply agreement with Dentsply Sirona. This agreement will add Kitron as a new supplier for Dentsply Sirona

Jun-16 - Septodont Company had launched a bioactive and biocompatible root canal sealer named BioRoot RCS.

May-16  - 3M acquired Semfinder, a leading developer of precise semantic coding of medical services.

May-16  - 3M     Knifeless Tech Systems was acquired by 3M. The business acquired is an installation tool used to cut self-adhesive films applied to vehicle wraps.

Apr-16    - Straumann acquired 51% residual ownership of Neodent. This deal augments Straumann's presence in the tooth replacement sector in the Latin American region and Brazil, which is the second largest market for implant dentistry.

Feb-16   - Septodont     Company acquired DLA, an injectable dental anesthetic manufacturing plant from Dentsply International.

Global Dental Infection Treatment Market   - Regional Analysis

US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the market for global dental infection treatment. The presence of large device companies in the developed regions is also a major driver of the market. Europe is the second largest market due to large disposable income and rising awareness regarding the health hazards of this condition. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-infection-treatment-market-4068 

Europe Dental Software Market to Witness Widespread Expansion During 2020 to 2023

 Market Scenario:

The Europe Dental Software market is expected to witness high growth in the coming years. The demand for dental software is dignified by improving process quality, patient satisfaction and speeding up the process for the treatments provided by dental organizations, and dental institutes. The growing availability of electronic data offers practitioners increased opportunities for reusing clinical data for research and quality improvement.
Considering the scenario of the Europe Dental Software market share, the total market was US$ 488.6 million in 2016 and expected to reach US$ 861.0 million by 2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3263 

Key Players for Europe Dental Software Market:          
Some of the key players in this market are: Carestream Health, Inc (US), Dentsply Sirona (US), Elite Computer Italia (OrisLine Group) (italy), Henry Schein, Inc (US), KaVo Dental GmbH (Germany), PLANMECA OY (Finland)
Segments:
Europe Dental Software Market has been segmented on the basis of type which comprise Practice Management Software, Patient Communication Software, Treatment Planning Software, Patient Education Software, and Dental Imaging Software. Patient management segment was holding largest market share. On the basis of application, it is segmented into Clinical Application, Administrative. Clinical application segment is dominating The European dental software market by application. On the basis of deployment, it is segmented into On-Premise Model, and Web-Based/ Cloud-Based Model. On-premise model is leading in this segment. On the basis of End User it is segmented into Hospitals & Clinics, Academics & Research Institutes. Hospitals and clinics was holding largest market share in 2016.

Regional Analysis of Europe Dental Software Market:     
Considering the scenario of Europe Dental Software market, Germany was holding largest market share of 20.6% in 2016 and is expected to reach 165.9 million by 2023. France is second largest country in Europe Dental Software market. UK is expected to grow at a CAGR of 7.6% during 2017-2023. On the other hand. Eastern Europe Dental Software market is growing significantly and is expected to grow at a CAGR of 7.4% during the forecast period.  

The report for Europe Dental Software Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/europe-dental-software-industry-3263 

Rabies Diagnostics Market Foreseen to Draw a Promising Growth by 2023

 

Market Highlights

Rabies is a life treating a viral disease which is caused by the biting of an infected rabid animal.  It is fever, headache, muscle aches, loss of appetite, nausea, and tiredness to the infected animal or human. The surge in the prevalence of rabies, increasing awareness about rabies, and a rising number of pet animals are expected to drive the global rabies diagnostics market growth during the forecast period. Moreover, ongoing research and development activities by non-profit organizations and aggressive strategies by top players such as mergers, expansion, and collaboration for the development of new products and new product launches by major players are also boosting the growth of the market. According to the report published by World Organization for Animal Health, Asia-Pacific region is hugely affected by rabies owing to the increasing cases of rabies, in Asia approximately 31000 deaths were caused by rabies which is 56% of the total cases. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7796 

The high costs associated with the diagnostic, absence of awareness about rabies and scarcity of skilled workforce may hamper the growth of the market during the assessment period.

Regional Analysis

The market is likely to dominate by Asia-Pacific during the forecast period owing to the improving healthcare infrastructure, increasing investments in the healthcare sector and expansions by market players in the region. Also, a country such as India and China are considering the fastest growing region due to a government focused toward adopting new technology, and the best treatment option from a developed country.

The Americas are expected to be the second-largest market in the global rabies diagnostics market due to the rising collaborative activities by major players, raising awareness about rabies, the involvement of non-profit organization to control rabies, and well-established healthcare infrastructure.

The European market is likely to hold a significant market share in the rabies diagnostics market. The government funding, well-established healthcare sector, and support of the healthcare sector coupled with increasing research and development are responsible for the growth of this market in the region.

The market in the Middle East & Africa is expected to account for the smallest share of the global rabies diagnostics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Segmentation

The global rabies diagnostics market has been segmented on the basis of method, technology, end-user, and region.

Based on method, the market has been classified as a fluorescent antibody test (FAT), immunohistochemical test, amplification methods, histologic examination, and serology tests. Global rabies diagnostics market on the basis of technology has been segmented into ELISA/immunohistochemistry, chromatography techniques, PCR, and others.

Based on market has been segmented into hospitals, diagnostic centers, cancer palliative care clinics, and others.

Key Players

Some of the key players in the global rabies diagnostics market are Bio-Rad Laboratories, Inc., Merck KGaA, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote, Inc., Express Biotech International Inc., MyBioSource.com., and BioGen Technologies

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/rabies-diagnostics-market-7796 

Enteral Feeding Devices Market: Information, Analytical Insights and growth of 2020 – 2023

 Market Highlights

The global enteral feeding devices market size held a market value of USD 2,302.4 million in 2017 and is projected to grow at a CAGR of 6.1% over the forecast period. Enteral feeding is the direct delivery of nutrients into the gastrointestinal tract (GIT) via a tube which is placed into the duodenum, jejunum or stomach through mouth, nose or percutaneous route. Major factors driving the market growth are globally growing geriatric population coupled with the rising burden of chronic diseases, increasing shift from parenteral to enteral nutrition, and mounting incidence of preterm births. For instance, according to the World Health Organization (WHO), in 2001, chronic diseases contributed around 60% of the 56.5 million total reported deaths across the world and approximately 46% of the global burden of disease, which is projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide. In contrast, complications associated with enteral feeding devices including inadvertent dislodgement of tubes and stringent reimbursement policies are anticipated to restrain the market growth during the next five years. Mounting technological advancement in feeding pumps such as enhanced portable pump designs with reduced risk of complications and is augmenting the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7828 

Regional Analysis

The global enteral feeding devices market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas would command the market over the forecast period pertaining to the presence of sophisticated medical and healthcare infrastructure and market value contributors, changing lifestyle, and the rising burden of cancer, and other noncommunicable diseases (NCDs). The American Cancer Society stated that in 2018, about 9,220 new cases of colon cancer have diagnosed in the US. 

Europe would be the second-largest value contributor in the enteral feeding devices market owing to the Asia-Pacific would represent the profitable market growth during the forecast period due to growth in geriatric population, rising incidence of oral cancer, and increasing awareness about enteric feeding devices, and surging number of hospital admissions in China, India, Japan, and Australia. The World Health Organization stated that in 2018, the incidence of oral cancer was within the top three of all cancers in a few Pacific Asian countries.

The Middle East & Africa has the least share of the global enteral feeding devices market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Segmentation

The global enteral feeding devices market has been segmented into product, age group, indication, end user, and region.

By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

On the basis of age group, the market has been divided into adults and pediatrics.

By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others.

Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs).

Key Players

Some of the spearheading players in the global enteral feeding devices market are Medtronic plc, Cook Medical, B. Braun Melsungen AG, Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company (BD), Fresenius Kabi AG, Danone Nutricia, Nestlé, CONMED Corporation, Moog, Inc., Halyard Health, Inc., and Vygon SA.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/enteral-feeding-devices-market-7828 

Global Foley Catheters Market Expected to Grow with a healthy CAGR

 Foley catheter mostly used when the patient have infection, swollen prostate or bladder stones for drain urine from the bladder. It is a hollow and flexible urinary drainage tube that passes through the urethra and urinary bladder to drain urine. It is the most common type of urinary catheters. It is designed with the purpose to left in place for short or long periods of time. Catheter are necessary till the time patient suffering with infection, swollen prostate or bladder stones not able to urinate on own. According to National Kidney Foundation, Inc., one in five women may suffer from urinary tract infections at list once in a lifetime. In 2015, it is estimated that around 150 million urinary tract infection occurs annually on a global basis. Report suggest that prevalence of urinary tract diseases is more in females in compare to males, 40% to 50% of whom will suffer at least one clinical episode during their lifetime. Besides this increasing prevalence of bladder cancer is also has a synergistic impact on the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/922  

Braun Melsungen AG (Germany), Coloplast Ltd (Denmark), Cook (US), Teleflex (US), Medline Industries, Inc. (US), and Medtronic (Republic of Ireland), C. R. Bard, Inc. (U.S.) are some of the leading players at the cutting edge of the competition in the market of foley catheters drug, globally.

Global Foley catheters Market – Overview

The global Foley catheters market report is showing the significant growth; mainly due to increase in patient population suffering with Urinary tract infection, kidney and other renal diseases. Also increasing in aging population is one of the major factor for the growth of Foley catheters market. According to National Kidney foundation, 10% of world’s total population was affected by chronic kidney disease in 2015. Foley catheters are consider very useful in treatment management of acute urinary retention and chronic urinary retention. According to American Society of Nephrology, around 26 million Americans are suffering from chronic kidney disease.

Companies are showing much interest toward the market of involuntary urination, as they feels there are huge opportunity and gap between the market demand and supply of effective treatments. Thus, companies are showing more interest in merger and acquisition activities for introducing quality product that meet the requirement of market. The development has been made by B. Braun Melsungen AG in 2016, they collaborate with Omnicell’s Performance Center and IV Automation Technology to increase system interoperability and to help reducing the time and clinical support needed to manage IV Infusions and IV compounding. Also in 2016, company launched the Only Macro and Micro Compounder with 26-lead preassembled sets the APEX Compounding System. It is the newest addition to B. Braun’s Clinical Nutrition 360 offering, which is a comprehensive approach to meeting the individualized clinical needs of patients and customers.

In 2015, C R Bard Inc. agrees to acquire Liberator Medical and has entered into a definitive agreement to acquire Liberator Medical Holdings Inc. by this acquisition C R Bard Inc. will improve its product portfolio as liberator medical has a strong list of products thus further improving its quality of products globally.

Global Foley catheters Market   - Regional Analysis

The market of foley catheters is much higher in the Americas region. There are huge population suffering with various urologic diseases. According to Urology Care Foundation, in 2015, quarter to a third of men and women in the United States were suffering from involuntary urination. Millions of the Americans are facing the problems of involuntary urination and about 33 million have overactive bladder representing symptoms of urgency, frequency and with or without urge incontinence.

Europe is also consider huge market for foley catheters players, owing to increasing number of hospitalized patients due to various medical complications. According to last statistics published by EUROPA in 2014, an average duration of hospital stay in the European country is 5.2 days to 10.5 days.

Asia Pacific and the Middle East and Africa region are considering the big market. Whereas country like India and china of Asia Pacific region are considering fastest growing region due to presence of huge population suffering with urologic diseases, additionally they are open to adopt new technology, and best treatment option from developed, this gap between the developed and developing countries will present significant growth opportunity for the foley catheters market players in the coming years. Whereas the Middle East and Africa are low market due to his incapability of investment.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/foley-catheter-market-922 

Global Dental Prosthetics Market is Expected to Experience Immense Growth During 2020 – 2023

 Overview

The Global Dental Prosthetics Market is expected to register a CAGR of 5.5% and is anticipated to reach USD 5659.4 Million by 2023. Dental prosthetics are mostly in use for the improvement of damaged or deficient teeth. It improves functions as well as the appearance of teeth. It also deals with the permanent or temporary replacement of missing teeth. Dental adhesives or screws are used to fix the dental prosthesis to teeth or dental implant.

The increasing number of dental caries, increasing per capita disposable incomes in emerging markets, rising dental tourism, and growing cosmetic dentistry treatments are the major drivers propelling market growth. However, the cost of dental procedures, the grey market of dental prosthetics, and slow adoption of new technology may hinder the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2905 

Market Dynamics

Dental caries is not only prevalent in children but also adults. About 1.8 million dentists are working around the world, and over 93% of WHO member states report having less than one dentist per 1000 population. 60%-90% of the children are facing dental problems, and the majority are from developed countries. Due to changing eating habits and increasing consumption of junk food and sugar are leading to an increase in several dental patients. Additionally, rising per capita disposable incomes in emerging markets, rising dental tourism, and increasing cosmetic dentistry treatments are driving the market growth. On the other hand, the cost of dental procedures, the grey market of dental prosthetics, and slow adoption of new technology are anticipated to hamper the market growth.

Segmentation

The global dental prosthetics market has been segmented into type, diagnosis & treatment, and end user. By type, the market has been divided into denture, crown, bridges, veneer, abutment, and inlays. The global dental prosthetics market, by type of material, has been segregated into porcelain-fused-to-metal (PFM), metal, all-ceramic, and others. By end user, the market has been divided into hospitals and clinics and dental research laboratories. The hospitals and clinics segment accounted for a market value of USD 3133.8 million in 2016.  

Key Players

The prominent players in the global dental prosthetics market are Henry Schein, Inc. (US), DENTSPLY Sirona (US), 3M (US), Institut Straumann AG (Switzerland), Zimmer Biomet (US), Nobel Biocare (Switzerland), Ivoclar Vivadent AG (Liechtenstein), Osstem Implant (South Korea), Planmeca OY (Finland), and CAMLOG Biotechnologies AG (Switzerland).

Some of the key strategies followed by the players operating in the global dental prosthetics market were innovation, product development, acquisition, and expansion.

Regional Analysis

The global dental prosthetics market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global dental prosthetics market during the forecast period. This is attributed to increasing incidences of periodontal diseases and the rising consumption of junk foods. The European market for dental prosthetics is expected to be the second-largest during the forecast period. The increasing geriatric population, which is a crucial target demographic, is expected to boost the growth of the market in this region.     

Asia-Pacific is estimated to be the fastest-growing market due to rising healthcare spending by governments across developing countries and medical tourism. Moreover, a large pool of the patient population, untapped markets, and favorable government policies are likely to provide good opportunities for market players in this region. Moreover, in the Asia-Pacific region, Australia accounted for a market share of 26.8% in 2016. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to limited access and healthcare affordability among the developing population.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-prosthetics-market-2905 

Genotyping Market Estimated to Witness a Staggering Growth by 2023

 Market Highlights

Genotyping is a procedure commonly used in healthcare and life sciences research activities. Genotyping is a genetic mapping of an organism which includes DNA sequencing and analysis of sequenced DNA. The surge in cases of genetic disorders, increasing demand for personalized medicines, and technological advancement are the factors that are propelling the growth of the market. Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market. For instance, in January 2018, Illumina, Inc. launched iSeq 100 Sequencing System in the market, the product contains sequencing by synthesis (SBS) along with the complementary metal-oxide-semiconductor (CMOS) detection technology which is easy to use and compact product.  

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6635 

The unfavorable reimbursement policies, the dearth of technicians, and continues change in technology are likely to hinder market growth during the forecast period.

Regional Analysis

The market in the Americas is expected to dominate the global genotyping assay market during the forecast period owing to the rising demand for personalized medicines, growing research and development sector, increasing cases of genetic disorders, and well-established healthcare sector in the region. The European market is expected to be the second-largest due to government funding and support of the healthcare sector, rising investment into research and development by pharmaceutical companies, and increasing government initiatives for development of healthcare sector. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing disposable income, supportive government policies, and rising investment by market players in the region. The market in the Middle East & Africa is likely to account for the smallest share of the global genotyping market.

Segmentation

The Global Genotyping Market has been segmented on the basis of technology, product, application, and end-user.

The technology segment has been segregated into sequencing, capillary electrophoresis, PCR, microarray, and mass spectrometry. The sequencing segment has been further divided into next-generation sequencing, pyrosequencing, and Sanger sequencing. The Capillary electrophoresis segment has been further divided into amplified fragment length polymorphism (AFLP),single-strand conformation polymorphism (SSCP), and restriction fragment length polymorphism (RFLP). The microarray segment has been classified as DNA microarrays, antibody microarrays, MMChips, and peptide microarrays.

On the basis of product, the market has been divided into reagents and kits, instruments, and services.

 The market, by application, has been classified into diagnostics, drug discovery and development, agriculture, academic research, and personalized medicine.

The end-user segment has been classified into hospitals, diagnostic centers, academic institutes, and research and development centers.

Key Players

Some of the key players in the global genotyping market are F. Hoffmann-La Roche Ltd, QIAGEN, Thermo Fisher Scientific, Inc., Illumina, Inc, Fluidigm Corporation, General Electric Company, Affymetrix, Inc., Agilent Technologies, Inc., Sequenom, and Beckman Coulter, Inc.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/genotyping-market-6635